Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
48.30
+0.31 (0.65%)
Real-time:   1:14PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 47.84 - 48.52
52 week 34.58 - 55.16
Open 48.02
Vol / Avg. 54,773.00/275,421.00
Mkt cap 1.62B
P/E 39.28
Div/yield     -
EPS 1.23
Shares 33.57M
Beta 1.42
Inst. own 100%
Mar 6, 2017
Q4 2016 Amedisys Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 3.18% -0.18%
Operating margin 3.97% -0.72%
EBITD margin - 6.88%
Return on average assets 6.44% -0.34%
Return on average equity 10.52% -0.75%
Employees 16,100 -
CDP Score - -

Address

3854 American Way Ste A
BATON ROUGE, LA 70816-4013
United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company's home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company's hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company's personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.

Officers and directors

Paul B. Kusserow President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Gary D. Willis Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Christopher Gerard Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Lawrence R. Pernosky Chief Human Resource Officer
Age: 62
Bio & Compensation  - Reuters
Michael Paul North Senior Vice President - Operations, Interim Chief Information Officer
Bio & Compensation  - Reuters
David L. Kemmerly Senior Vice President - Government Affairs, General Counsel
Age: 53
Bio & Compensation  - Reuters
Jeffrey D. Jeter J.D. Chief Compliance Officer
Age: 44
Bio & Compensation  - Reuters
Jane Carmody Chief Clinical Operations Officer
Age: 64
Bio & Compensation  - Reuters
Stephen Seim Chief Strategy Officer
Age: 52
Bio & Compensation  - Reuters